Does an implantable cardioverter-defibrillator improve overall survival in survivors of ventricular fibrillation or sustained ventricular tachycardia compared to antiarrhythmic drugs?
Implantable cardioverter-defibrillators are superior to antiarrhythmic drugs for increasing overall survival in patients resuscitated from near-fatal ventricular arrhythmias.
Among survivors of ventricular fibrillation or sustained ventricular tachycardia causing severe symptoms, the implantable cardioverter-defibrillator is superior to antiarrhythmic drugs for increasing overall survival.
The Antiarrhythmics versus Implantable Defibrillators Investigators (Thu,) studied this question.